Antimicrobial resistance in Staphylococcus aureus

T L Smith1, W R Jarvis

  • 1Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

Insights

Staphylococcus aureus infections are a growing threat due to antimicrobial resistance. Understanding resistance is key to effectively treating these dangerous infections and preventing a return to high mortality rates.

Area of Science:

  • Microbiology and Infectious Diseases
  • Antimicrobial Resistance Research
  • Clinical Medicine

Background:

  • Staphylococcus aureus has been a recognized cause of infection since 1883.
  • The pre-antimicrobial era saw an 82% mortality rate for S. aureus bacteremia.
  • Emerging vancomycin resistance in S. aureus threatens to reverse treatment successes.

Purpose of the Study:

  • To highlight the increasing threat of Staphylococcus aureus infections.
  • To emphasize the critical need for understanding antimicrobial resistance in S. aureus.
  • To underscore the importance of this knowledge for successful treatment outcomes.

Main Methods:

  • Review of historical and current data on Staphylococcus aureus infections.
  • Analysis of trends in antimicrobial resistance, particularly vancomycin resistance.
  • Assessment of the impact of resistance on treatment efficacy and mortality rates.

Main Results:

  • Growing vancomycin resistance is undermining a key treatment for S. aureus.
  • The potential for a return to high mortality rates associated with S. aureus bacteremia.
  • Antimicrobial resistance capacity is a critical factor in treatment success.

Conclusions:

  • Effective treatment of Staphylococcus aureus infections is increasingly challenging.
  • Knowledge of S. aureus antimicrobial resistance patterns is essential for clinical practice.
  • Proactive strategies are needed to combat rising resistance and improve patient outcomes.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...